Atrial Fibrillation Surgery Market Analysis

  • Report ID: 4857
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Atrial Fibrillation Surgery Market Segmentation:

Procedure Segment Analysis

The global atrial fibrillation surgery market is segmented and analyzed for demand and supply by procedure into catheter ablation, surgical ablation, and AV node ablation. Out of the three types of atrial fibrillation surgery, the catheter ablation segment is estimated to gain the largest market share of about 38% in the year 2035. The growth of the segment can be attributed to the increasing effectiveness of catheter ablation procedures. This procedure is used to treat irregular heart rhythms especially when medicines and drugs seem to have no effect. This is considered a low-risk, minimally invasive, and highly precise treatment pathway. Catheter ablation has a 95% of success rate in the treatment of cardiac arrhythmias. Further, the new product launches by key players in the industry are also estimated to boost market growth. For instance, the TactiFlex PAF IDE ablation catheter was launched by Abbott Laboratories and is used to treat an irregular heartbeat. These factors are estimated to contribute to the growth of the segment in the forecast period.

End-user Segment Analysis

The global atrial fibrillation surgery market is also segmented and analyzed for demand and supply by end-user into hospitals, ambulatory surgical centers, and others. Among these three segments, the ambulatory surgical centers segment is expected to garner a significant share of around 40% in 2035. As a consequence of enhanced health infrastructure, availability of skilled labor, and affordability, the ambulatory surgical center segment is expected to see good growth. The rising patient pool and growing geriatric population suffering from lifestyle diseases, such as atherosclerosis and heart failure, are expected to propel the market. However, the advantages of minimally invasive surgeries ultimately lead to a growth in segments as opposed to conventional surgery. On January 2021, the Pathways organization has introduced a top membership program for ASCs, HST One. With the option of adding additional services as required, this membership program allows its end users to select from a selection of bundled popular products in which they themselves take part. The introduction of such differentiated services to ambulatory surgery centers increases the number of patients, which contributes to market growth. This, as a result, is anticipated to create numerous opportunities for the growth of the segment in the coming years.

Our in-depth analysis of the global market includes the following segments:

     By Procedure

  • Catheter Ablation
  • Surgical Ablation
  • AV Node Ablation

     By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of atrial fibrillation surgery is evaluated at USD 5.21 billion.

The global atrial fibrillation surgery market size exceeded USD 4.65 billion in 2025 and is set to expand at a CAGR of over 13.4%, surpassing USD 16.35 billion revenue by 2035.

The North America atrial fibrillation surgery market is expected to hold a 32% share by 2035, driven by technological advancements, increasing prevalence of cardiac conditions, and favorable insurance coverage.

Key players in the market include Abbott Laboratories., AtriCure, Inc., Biosense Webster, Inc., Boehringer Ingelheim GmbH, Boston Scientific Corporation, Bristol-Myers Squibb Corporation, CardioFocus, Inc., Endoscopic Technologies, Inc., Sanofi Aventis, Johnson and Johnson Ltd.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos